Inhibition of pancreatic cancer cell growth

T E Adrian1

  • 1Department of Physiology, Faculty of Medicine and Health Sciences, United Arab Emirates University, POBox 17666, Al Ain, United Arab Emirates. tadrian@uaeu.ac.ae

Insights

Pancreatic cancer cells resist chemotherapy due to genetic changes. This review explores strategies to overcome this resistance and induce cancer cell death, focusing on apoptosis pathways.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Pancreatic cancer exhibits significant resistance to conventional chemotherapeutic agents.
  • Carcinogenesis involves genetic and epigenetic alterations enabling cancer cell survival and evasion of apoptosis.
  • Understanding these resistance mechanisms is crucial for developing effective treatments.

Purpose of the Study:

  • To review the mechanisms underlying pancreatic cancer cell resistance to chemotherapy.
  • To summarize pathways involved in promoting cancer cell death and apoptosis.
  • To highlight recently developed strategies for inducing apoptosis in pancreatic cancer.

Main Methods:

  • Literature review of pancreatic cancer biology and treatment resistance.
  • Analysis of genetic and epigenetic factors contributing to chemoresistance.
  • Synthesis of information on apoptosis-inducing pathways and novel therapeutic strategies.

Main Results:

  • Pancreatic cancer cells possess inherent resistance mechanisms to standard chemotherapy.
  • Multiple genetic and epigenetic events contribute to the evasion of apoptosis.
  • Various strategies are being developed to target these resistance pathways and induce cell death.

Conclusions:

  • Overcoming chemoresistance in pancreatic cancer requires targeting specific molecular pathways.
  • Novel strategies focusing on inducing apoptosis offer promising therapeutic avenues.
  • Further research into these pathways can lead to improved treatment outcomes for pancreatic cancer patients.